TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive OSU Continues As comprehensive Center; City Of Hope BMT Program Wins 5-Year Grant. July 14, 2000